http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114989311-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01a3d3d8bbed1d862b9fb73159ce2679
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-19
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2851
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
filingDate 2022-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_507eba8286fc5fb3d58968d0dfed0340
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de58f8d3b8ff67c8333333db6ee42072
publicationDate 2022-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114989311-A
titleOfInvention 3G9-LNM antibody conjugated protein and its preparation method and application
abstract The present invention discloses a 3G9-LNM antibody-coupled protein and a preparation method and application thereof. The protein is obtained by combining a tumor antigen and an antibody by breaking intein trans-splicing. The amino acid sequence of the protein heavy chain is shown in SEQ ID NO: 10, The amino acid sequence of the light chain is shown in SEQ ID NO: 6, and the light chain does not participate in the reaction. The 3G9-LNM antibody-coupled protein provided by the present invention, as well as the preparation method and application thereof, overcome the problems such as the need to add chemical reagents, certain toxicity, unstable chemical coupling, and easy breakage of coupling bonds in the existing antigen-antibody coupling method, The connection using the split intein GP41-1 trans-splicing method is connected by peptide bonds, which has higher stability, stronger specific binding, mild reaction conditions, high efficiency, simple process, and no toxic and harmful substances are added. It will not produce by-products, etc., with high safety, and provide technical support and new ideas for the research and development of new tumor vaccines.
priorityDate 2022-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ06SH2
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID427801
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID246100
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1KVQ9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP10439
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09963
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460839
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP62692
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61365
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP33486
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6XQ98
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9TKU7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07540
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00720
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9T1T5
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID501655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451186576
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9T1X2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ37896
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP78285
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID70062
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID427801
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19385
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13559
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP68921
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ20EU8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19386
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ86AA1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP68920
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7Y2C0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ37875
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51728
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO80288
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO64362
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ556F2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11187
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO80292
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP62693
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27359
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30848
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9ZXB7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP76159
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451774801

Total number of triples: 75.